What can clonal evolution in chronic lymphocytic leukemia (CLL) tell us about outcomes?
ASCO 2016 highlights for multiple myeloma
How clinicans should talk to CLL patients about their hopes and expectations
What is the role of allogeneic stem cell transplantation in CLL in the light of novel drugs?
Reporting positive treatment outcomes with bendamustine + rituximab in indolent lymphomas
Mathias J Rummel